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I. 
The  serum  treatment of  epidemic meningitis,  developed  during 
the prevalence of the pandemic beginning in 19o  4 and not yet wholly 
at an end, has now been subjected to a  rigorous test extending over 
a period of six years and embracing many different countries.  The 
results of this trial have thus far been published in part only.  The 
present publication deals with the analysis of the histories of cases, 
about  1,3oo  in  number,  that  were  treated  with  the  antimeningitis 
serum prepared  and distributed by the Rockefeller Institute.  The 
histories have been collected not only from many different parts of 
the United States and Canada but also from several European and 
Asiatic countries to which the serum was sent.  The large number 
of the cases and the diversity of the circumstances under which the 
serum came to be administered give to the following presentation a 
significance greater  perhaps  than  that  afforded by  a  strictly local 
report.1 
BIOLOGICAL DISTINCTIONS AMONG  MENINGOCOCCI. 
The  bacteriological  cause  of  epidemic  meningitis  is  admittedly 
Diplococcus  intracellularis.  Formerly  no  fundamental  biological 
distinction  was  made  between  meningococci;  now  differences  of 
* Received for publication, March I,  1913. 
1  The 1,3oo cases include the 712  eases previously analyzed (Jour.  Am. Med. 
Assn.,  19o9, liii, I443).  The  number o5  physicians and  hospitals making the 
reports is too great to enable me to thank them individually.  In a previous paper 
(Jour.  Exper. Med.,  I908  ,  x,  69o) many  acknowledgments were made, to which 
I desire now to add the name of Professor A. Netter, of Paris, for his invaluable 
services. 
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virulence  for  animals,  degree  of  digestibility  in  leucocytes,  and 
power of resistance to  solution by immune serum are being recog- 
nized.  The  pathogenicity  of  the  meningococcus  for  laboratory 
animals  is not great, but by the intraperitoneal injection of young 
guinea pigs  the virulence can be  tested  and  different strains  more 
or less  pathogenic can be  distinguished.  Some strains  maintain a 
given virulence for a year or more and others lose this quality very 
soon  after  being  obtained  from  human  sources.  Rarely  a  strain 
that  shows  no  virulence  for  guinea  pigs  takes  on  suddenly  a 
heightened activity.  There is no sharp agreement in pathogenicity 
between strains that are virulent for guinea pigs and those virulent 
for monkeys or man.  Some strains, but not all, can be adapted by 
successive inoculation to guinea pigs  and to monkeys. 
Opsonic  experiments have  disclosed  the  fact  that  meningococci 
derived from different sources are digested by leucocytes with vary- 
ing facility.  The kind of leucocytes employed appears unimportant 
and  even the  sera,  whether  normal  or  immune,  play  no  obvious 
distinguishing  part;  the  variations  depend  upon  the  strain  of 
meningococcus.  All  meningococci  are  readily  phagocyted  in  the 
presence of serum and dissolved ultimately by leucocytes; but while 
many strains are quickly digested, a  small number resist disintegra- 
tion far more tenaciously.  In estimating the content of opsonizing 
substances in different samples of antimeningococcic sera the strains 
digesting slowly should be chosen. 
Whether  in  meningitis  in  man a  similar  variation among men- 
ingococci occurs naturally can only be inferred.  Exudates,  as ob- 
tained from different cases of epidemic meningitis, differ in number 
and  distribution  of the contained meningococci.  At  one time the 
number of meningococci is small and at others large, and sometimes 
the meningococci lie chiefly within cells, while at others they occur 
mainly free in the fluid. 
Under the influence of the antimeningitis serum injected into the 
subdural space the diplococci come, as a  rule, to lie more and more 
within  the  leucocytes.  As  recovery  from  meningitis  progresses, 
even  where  no  antiserum  has  been  employed,  a  corresponding 
phenomenon  is  noted.  Moreover,  the  meningococci  phagocyted 
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tion.  In how far resistance to solution in leucocytes is due to the 
quality of fastness of the meningococcus to the action of the intra- 
leucocytic enzymes is not certainly known; nor is it known definitely 
that  the less  readily englo.bed meningococci consist  also  of  strains 
that  are  more  or  less  resistant  to  immune  opsonins  or  bacterio- 
tropins.  But  indications  exist  supporting  the  view  that  certain 
examples of epidemic meningitis in man which respond imperfectly 
to the therapeutic action of the serum are caused by strains of men- 
ingococci  fast  to  the  antiserum  employed.  These  strains  tend  to 
remain persistently extracellular and to multiply freely in the pres- 
ence of the antiserum, even under conditions of its high concentra- 
tion in the subdural space.  The cases of human infection with the 
supposedly resistant  strains  fail  not  only to  respond to  the  thera- 
peuti.c  action  of  the'antiserum  but  can  be  inferred  also  not  to 
ameliorate  spontaneously  and  thus  tend  to  a  fatal  termination. 
Certain biological differences have been noted among meningococci 
from different sources.  These  relate  to  the  readiness  with  which 
they can  be  cultivated,  to  survival  in  cultures,  and  fluctuation  in 
power  to  ferment carbohydrates.  The  variations  in  opsonic  and 
leucocytic reactions would seem .to be of a  more fundamental char- 
acter, just as they are of greater significance in respect to the patho- 
genic power of the meningococcus and to better control of epidemic 
meningitis by the employment of the antimeningitis serum. 
MORTALITY  OF  EPIDEMIC  MENINGITIS. 
The  establishment  of the  bacterial  cause and  the  perfection of 
lumbar puncture made it possible, as never before in a widely spread 
epidemic  of  meningitis,  to  ascertain  accurately  the  degree  of  its 
fatality.  Mortality  estimates  based  on  earlier  epidemics  are  far 
less trustworthy since they obviously could not have rested on such 
certain  evidence  of  specific  disease.  The  pandemic  of  19o4-  9 
afforded,  therefore,  the  first  opportunity  to  determine  the  actual 
mortality of epidemic meningitis as it affects countries and peoples 
of  various  nationalities  and  widely different social  customs.  Ac- 
curate  knowledge  of  t'he  mortality  becomes  imperative  once  we 
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prehensive and accurate figures are available from the United States 
and Canada, Great Britain and Ireland, Germany, France, Belgium, 
and Italy, and Asia and Africa.  The facts to be given immediately 
relate  ex.clusively to  the  disease  as  it  prevailed  either  before  the 
serum  treatment  was  introduced,  or  where  it  had  not  yet  been 
applied. 
In  the period  from  19o  4  to  19o9  epidemic meningitis  prevailed 
over a wide territory in the United States and Canada, and after an 
intermission reappeared in the winters of  191I-I2  and  1912-13  in 
the Southwestern States.  The  fatalities recorded at several places 
are as  follows:  Greater New York  City,  73  per  cent.;  Boston,  69 
per cent. ; H.artford,  76  per cent.; several cities  in Ohio,  7  °  to 9o 
per  cent.;  Porterville,  California,  9 °  per  cent.  During  1911-12 
more than  1,5oo cases arose in Texas and Louisiana among which 
(exclusive of cases treated with  serum)  the mortality was  75  per 
cent. or more. 
The  epidemic  in  Great  Britain  was  equally  severe.  The 
mortality reports  include Leith,  74.7  per cent. ; Edinburgh,  8o per 
cent. ; Glasgow, 74.8 per cent., and Belfast, 7 °  per cent. 
The largest German figures relate to the Silesian epidemic.  The 
lowest mortality reported is based on a  group of 47  cases at Brieg 
and  is  42. 5  per  cent.,  while  in  Breslau  it  was  62. 3  per  cent.,  and 
among the 3,o85  cases collected by Flatten,  67  per cent. 
The mortality in France was placed by Netter at 75 per cent. ; in 
Belgium it is given at 77.7 per cent. ; while the degree of fatality in 
Italy may be deduced from the  figures  for  Milan  which are  55.6 
per cent. 
The  reports  from  Asia  and  Africa  are  few  but  they  indicate 
severe infection.  In Palestine the mortality was above 8o per cent. ; 
in Greece (Athens)  58.6 per cent. ; and in the Transvaal 74 per cent. 
Although accurate figures are not available,  the epidemic prevailed 
in Java and in German East Africa. 
The  statement of yon Ziemssen may be taken as  a  criterion of 
the views held in prebacteriologieal days of the severity of epidemics 
of meningitis.  He  states  that the mortality fluctuates between 3 ° 
and  7  °  per cent., the average being about 4o per cent.  There is, 
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this  manner,  and  the  artificiality is  brought  out  strikingly  by  the 
reliable figures of the recent pandemic. 
There appears  to have been little  variatior~ in 'the mortality ac- 
cording to  the  period  at  which  the epidemic flourished,  and  as  it 
affected the  inhabitants  of  the mining  districts  of  Northern  Ger- 
many  or the  Tratmvaal,  the  industrial  populations  of  Ireland  or 
Scotland, the general population  of France,  the military garrisons 
of  Belgium,  the  urban  population  of  New  York  or  Boston,  the 
suburban population of remote districts in Ohio,  California, Texas, 
and Louisian,  a, or the agricul.tural and artisan peoples of Greece and 
Palestine.  Everywhere the upper limits of yon Ziemssen's figures 
were reached or surpassed.  Hence it appears that the virulence of 
the meningococcus was the chief factor in causing death, and differ- 
ences among peoples, as  represented by race and  occupation,  were 
far less conspicuous factors. 
Meningococcus meningitis  prevails  also  as  a  sporadic  affection. 
The mortality of the sporadic disease is  far more difficult to deter- 
mine than that of the epidemic disease for the reason that vital sta- 
tistics covering wide areas are difficult to obtain.  Such data as are 
available  tend  to  show  that  the  sporadic  disease,  when  bacteri- 
ologically diagnosed, is  less  fatal  than the epidemic disease.  Pos- 
terior  basic  meningitis,  which  is  probably  merely  a  variety  of 
sporadic  meningitis,  has  a  less  general distribution.  This  disease 
had  claimed  attention chiefly in  England.  The  fatality  of  these 
affections may fall as  low as 4o  to 5o per cent. 
MODE  OF TERMINATION 
Cases  of meningitis are very varied both  in  respect to their  in- 
tensity and evolution.  In rare individual instances the disease sets 
in  severely  and  yet  terminates  in  recovery,  sometimes  in  a  few 
days,  or the onset is mild although ,the infection later develops an 
alarming gravity; while again the disease progresses slowly or con- 
tinuously through weary weeks or months  to end usually, but  not 
always,  in death.  The cases of ordinary severity pursue a  middle 
course, while the  fulminant ones arise and terminate within a  few 
to  forty-eight hours.  There  remains  still  another  variety  of  the 
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known;  namely,  the ambulant.  The  subjects  are  commonly little 
ill at any time, so t.hat  recovery is  the rule.  Nevertheless, in  rare 
instances death may suddenly supervene, =and somewhat more often 
the  slight  illness  increases  in  severity  until  the  ordinary  type  is 
evolved. 
Neither the  synlptoms nor  the  mode  of their  evolution  support 
a  prediction  as  to  the  probable  outcome  of .the  disease.  Several 
different types have been constructed out of the variety, complexity, 
and degree of severity of the symptoms, but a  sharp discrimination 
between  them  is  often  wanting  in  practice.  For  this  reason  ob- 
servation of individual cases affords little final information concern- 
ing the nature  of  epidemic meningitis,  and  the .outcome of  single 
cases  is  an  uncertain  guide  to  the  value  of  a  given  therapeutic 
measure. 
Death  may  be  considered  as  taking  place  under  three  sets  of 
circumstances:  (a)  rapidly,  after  sudden  onset  of  illness,  as  in 
meningitis  siderans,  or  so  called  fulminating  meningitis;  (b) 
through a gradual intensification of the symptoms and after a dura- 
tion  of  from six to  ten  days;.  (c)  slowly,  in the course of  which 
the  acute stage has been  survived .and  after the  condition has  be- 
come chroni,c. 
Recovery, also, when it occurs is not by a single mode of termina- 
tion,  but by at  least  two  modes.  T,he transition  to  convalescence 
and recovery is generally by a  process of gradual  amelioration of 
the symptoms, or lysis.  Sometimes, but more rarely, the transition 
takes place abruptly by a  sudden or critical cessation of the symp- 
toms  that  follow quickly upon the  onset of the  infection  or  after 
several days have elapsed. 
Knowledge is  lacking of the  relative  frequency with, which the 
several  types  of  meningitis  occur  in  different  epidemics.  What 
would be particularly informing is  accurate knowledge of the  fre- 
quency  of  the  extreme  cases--the  fulminant  and  the  abortive, 
latent,  rudimentary,  or  ambulant  ones,  so  called.  The  t,hrowing 
together of the abortive and ambulant cases is  not strictly justified 
by their usually mild ,character,  since the  one  sets  in  sharply  and 
the other begins insidiously.  While the former tends to  terminate 
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ing in.to the severe or even fulminant disease.  That such mild cases 
of epidemic meningitis  occur has  now been conclusively  shown  bv 
bacteriological  examination  of fluids  removed by lumbar  puncture. 
Exceptionally an epidemic has been composed mainly .of them, as in 
Kehl.  In  many  epidemics  they  have  wholly  escaped  detection. 
Apparently their occurrence is infrequent, and excellent observers of 
large numbers of cases of epidemic meningitis h.ave not encountered 
them. 
The  proportion  of  fulminant  'to  ordinary  cases  can  be  inferred 
rather  than  asserted.  At  the beginning  of a  severe epidemic  they 
appear to be more frequent than at the end.  Certain epidemics have 
been noted  for their  absence.  On the other hand,  fulminant  cases 
have  appeared  in associated  groups,  one  case  following another  in 
rapid  succession in barrack,  school,  or  family.  Some idea  of  fre- 
quency can  be inferred  from  the  duration  of  the  illness  preceding 
death.  The  chief  danger  in  this  inference  arises  from  the  uncer- 
tainty  surrounding  the  period  of  onset  of  some  of  the  cases. 
Among  1,481  fatal  cases  analyzed  by Flatten,  29  died  within  six, 
3 °  in  from  six. to  twelve,  and  53  in  from  twelve .to  twenty-four 
hours of the appearance of symptoms.  That  is,  112, or 9 per cent., 
succumbed  within  the  first  twenty-four  hours,  while  another  III 
cases  terminated  fatally  in  the  second  twenty-four  hours,  giving 
18  per  cent.  of  the  whole  as  having  suffered  from  the  fulminant 
disease. 
DURATION  OF  THE  DISEASE. 
The duration may be considered according to the period elapsing 
before  either  death  or  recovery  occurs.  Among  the  1,481  fatal 
cases just  mentioned,  361,  or  25  per  cent.,  terminated  in  the  first 
three days; 351 , or 24 per cent.,  from the fourth to the seventh day; 
and  almost  5o  per  .cent.  later  than  the  seventh  day  of  illness. 
Hence, it cannot be maintained that the survival of the first week of 
the  infection  affords  great  insurance  of  ultimate  recovery.  One 
half  of the  cases surviving  the  first  week  terminated  between  the 
fifth and eighth weeks, while 7 per cent.  (107 cases)  survived eight 
weeks  or  longer.  Among  Schneider's  8o  fatal  cases,  26,  or  32.5 
per cent., succumbed in the first three days; 18, or 22. 5 per cent.,  in 
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Viewed  from the side of recovery the period of duration of the 
disease has fluctuated with the type.  The abortive cases are said to 
terminate in  recovery in  from .one and one half to  five days  (yon 
Ziemssen,  Striimpell).  Striimpell  states  that  the  critical  period 
falls between the fifth and tenth days, when either death results or 
convalescence begins.  Schneider's  analysis  of  52  .cases  shows  3 
recoveries from the fifth to the ninth day, 26  from the eleventh to 
the fortieth day, and 45  from the forty-first to the one hundred and 
tenth day.  Rieger di.scharged 25 patients  from the hospital on the 
average of the fortieth day.  Heubner states that the average dura- 
tion of the disease terminating in lysis is three to four to six weeks; 
yon Ziemssen gives for favorable cases two to three weeks, and for 
less favorable ones three to four weeks.  Holt states that in the New 
York  epidemic of  I9O4-5,  among 35o  cases  which  recovered, the 
duration in 3 per cen.t, was one week or less, and in 5o per cent. five 
weeks or longer. 
Thus  we  may conclude that  in  the  recent past  the  tendency of 
epidemic  meningitis  has  been  to  terminate  in  death,  and  of  the 
fatalities about one half arose in the first week .of the illness.  On 
the other hand, among the recoveries a  small percentage took place 
in the first week,  and almost all after several weeks or months of 
illness. 
INCIDENCE  AND  .MORTALITY  ACCORDING  TO  AGE. 
Young  persons  are  more  subject  than  older  ones  to  epidemic 
meningitis.  This  conclusion,  arrived  at  by  Hirsch  and  others,  is 
supported by recent more accurate studies.  Certain epidemics affect 
children almost  entirely,  and  nurslings  rather  than  older  children 
(Hirsch,  Heubner).  Among the 2,916  cases in  Silesia  in  I9O4-  5 
analyzed by Flatten, 247 .arose in the first, 239 in the second, 293  in 
the  third,  334  in  the  fourth,  and  27I  in  the  fifth  year.  Hence 
about one half  (I,384)  of the cases occurred in the first five year 
period, one third  (844)  in the second, one eighth (338)  in the third 
corresponding  period,  and  the  remainder  (350)  later  than  the 
fifteenth year of life.  Ggppert noted among 629  cases  IO2,  or  17 
per cent., in nurslings.  Since in children below three years of age 
the symptoms of meningitis are often masked,  it  follows  that  the Simon Flexner.  561 
bacteriological  diagnosis  accounts  for  the  greater  number  of  in- 
fants shown to be attacked during the pandemic. 
The  mortality  is  affected by  the  age  of  the  attacked.  Hirsch 
states that the disease is most fatal in children and in adults after the 
fortieth  year.  During  the  epidemic  in  New  York  the  mortality 
among infants of two years and under approxima.ted  IOO per cent. 
Flatten's figures based on the Silesian epidemic show approximately 
the same result.  The number of cases analyzed was 2,976.  They 
may be  divided as  follows: under one year, 255  with 89  per cent. 
of  deaths;  under two  years, 243  with 83  per cent.  of  deaths; be- 
tween two and five years, 866 with 72 per cen~t, of deaths; between 
five and ten years, 92o with 62 per cent. of deaths ; between ten and 
fifteen years, 346 with  56 per cent.  of deaths; between fifteen and 
twenty years,  187 with 63 per cent. of deaths; between twenty and 
thirty years, 76 with 59 per cent. of deaths ; and between thirty and 
seventy years, 83 with 83 per cent. of deaths. 
Hence,  in  the past,  epidemic meningitis  has  been most  fatal  to 
infants  and  adults after the  third or  fourth decennium, while the 
intermediate  age  periods  have  been  somewhat  more  favorable  to 
spontaneous recovery.  The favorable period begins to be apparent 
about the fifth year and endures until the twentieth or thirtieth year, 
when it diminishes with increasing rapidity as age advances. 
COMPLICATIONS  AND  SEQUELS. 
We shall consider briefly the chief complications and sequels only. 
The common secondary infections of the respiratory tract, etc., will 
be neglected.  In some instances the meningococcus causes a  com- 
plicating  pneumonia,  endocarditis,  or  serositis  exclusive  of  the 
joints;  in very rare instances  it  has  produced general infection or 
septicemia. 
Of greater importance are the involvements of the central nervous 
system, peripheral nerves, and sense organs in the infective process. 
True  motor  paralyses  occur infrequently and  permanent  ones  are 
rare.  Of  the  nerves  of  the  h.ead  the  facial  and  hypoglossal  are 
oftenest  affected.  The  frequency  has  varied  with  different  epi- 
demics and the complication has been noted  in abortive as well as 
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paresis,  a  rare  condition,  affecting  an  arm  and  less  .often  a  leg, 
comes on usually later than the second week.  These paralyses, re- 
garding  which  figures  are  scant,  are  attributed  to  focal  lesions  in 
the brain and spinal cord extending inward from the meninges. 
The  ear complications are numerous.  Both  the middle  and  in- 
ternal ear may be affected.  Inflammation of the middle ear is fre- 
quent and increases with the duration of the illness.  Thus  35  per 
cent.  of  the  inflammations  arise  in  the  first,  7o  per  cent.  in  the 
second, and 59 per cent. in the fourth to the sixth week (G6ppert). 
Recovery tends to be complete.  Inflammation of the internal ear is 
far  more  serious.  The  frequency  varies  in  different  epidemics. 
Percentages range from 33  (Mannkopff and Heller), 16 (G6ppert), 
and  12  (Bauer).  Probably 12 per cent. approximates the average 
among  large  numbers  of  cases  (G6ppert).  The  involvement 
usually occurs early in  the  attack  and  arises  even in  the  abortive 
disease.  Both ears tend to be affected and hearing is often already 
lost when the patients  enter the hospital.  Among sixty-four cases 
Moos observed affections of one side in three.  When the accident 
occurs  in  infancy  deaf-mutism  results.  Following  epidemics  of 
meningitis  the  number  of  deaf-mutes  in  institutions  has  greatly 
increased. 
The  eyes  may  suffer  slightly  or  severely,  and  injury  may  be 
temporary or permanent.  Muscular affections are common ( 12 per 
cent.),  ptosis  is  rare,  and pupillary  irregularities are  frequent  (24 
per cent.) ; all tend to be temporary, except ptosis.  Iritis and irido- 
choroiditis, retinitis, and periretinal hemorrhages all arise but often 
disappear  without  causing  permanent  injury.  Keratitis,  with  or 
without ulceration of the cornea, occurs, followed either by recovery 
or loss of the eye.  A  condition of basilar  amaurosis,  from which 
slow  recovery has  taken place,  has  also been described  (G6ppert). 
The most serious complication is metastatic ophthalmia,  due to  the 
meningococcus, affecting one eye or both, and leading to destruction 
of the ball.  Eye complications have been a  variable  factor in dif- 
ferent  epidemics.  G6ppert  reports  I4  instances  of  metastatic 
ophthalmia  (affecting both  eyes in 4,  and one eye in  io patients) 
among  r36  cases  (Io  per cent.).  Uhthoff states  that  among  iio 
Silesian cases lesions  of the optic nerve occurred in  17,  metastatic Simon Flexner.  563 
ophthalmia  in 4,  and keratitis  in  3-  Morax  noted  iridocyclitis  in 
from 3 to 6 per cent. of cases during the Parisian epidemic. 
The higher intellectual centers of memory, intelligence, and speech 
suffer  also,  but  while  slight  degrees  of  affection  from  which  re- 
covery takes  place  are  common,  only  rarely  does  permanent  in- 
capacitation result.  Actual mental defects of permanent character 
arise, according to G6ppert, in from I to 3 per cent. of the recovered. 
Looft reports that among 539  Norwegian idiots, 3.7 per cent. were 
caused by epidemic meningitis. 
Finally,  hydrocephalus  arises  very  often,  especially  among  the 
young.  In  Silesia  its  occurrence was  noted  in  one  eighth  of  all 
cases.  Recovery may occur without mental defect even where the 
degree is considerable.  Deafness and hydrocephalus are frequently 
associated, but not as cause and effect. 
II. 
We may now proceed to consider what changes have been effected 
in the course and consequences .of  epidemic meningitis by the em- 
ployment of the antimeningitis serum.  The serum began to be em- 
ployed in  19o6-7,  first locally and  later more generally.  Thus  it 
failed to  be used  in certain places because the epidemic wave had 
passed, and in other places its employment was begun at the middle 
period  or  height  of  the  epidemic,  according  to  circumstances. 
There occurred  coincidentally, almost  without  exception,  cases  of 
equal  severity  in  which the  serum  was  not  administered.  These 
served as checks, or controls.  The mortality in them did not vary 
essentially  from  the  figures  already given  for  different countries 
page  556).  The analysis to  follow is  based upon cases treated in 
America,  Europe,  Asia,  and  Australia  with  the  serum which was 
prepared  at  the  Rockefeller  Institute  by  a  uniform  method  and 
widely distributed, and they therefore present at least this common 
factor.  The chief variable was the experience or lack of experience 
in  those  charged  with  the  administration  of  the  serum,  which  is 
sometimes reflected in  the  results  achieved.  But  since this  factor 
will  always operate in  some degree, the results probably  approach 
the normal. 
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meningitis has been pointed out; hence it will not be as profitable to 
study the influence on individual cases as to consider the effects on 
the mortality and some o daer objective features of the disease. 
MORTALITY  OF  SERUM-TREATED  CASES. 
The number of cases to be subjected to analysis is  1,294.  They 
have  not  been selected and  a  single  exclusion has  been practised. 
In order to deny no one the benefits of the treatment where avail- 
able,  a  small number of hopeless and dying persons were injected. 
When  they survived  the  injection merely a  few 'hours--less  than 
twenty-four ,at  the maximum--they were not  included.  The  ful- 
minant cases have been included in the analysis and, as will appear, 
they  now  seem  not  to  be  without  the  sphere  of  influence of  the 
serum.  Tl:e general mortality is shown in table I. 
TABLE  I. 
Mortality  of Serum-Treated  Cases. 
No. of cases.  Recovered.  ]  Died.  Per cent. died. 
1,294  ]  894  400  I  30.9 
That the period of injection in the course of the disease affects 
the  fatality  has  been  previously  shown3  The  larger  number  of 
cases has been analyzed from this point of view and in accordance 
with  the  arbitrary  periods  previously  employed.  The  results  are 
shown in table II. 
TABLE  II. 
Mortality  according  to  the  Period  of  Injection  of  the  Serum, 
Period of injection.  No. of  Per cent.  Per cent.  cases.  Recovered.  Died.  recovered,  died. 
tst to 3d day.  199  163  36  81.9  18.i 
~th to 7th day..  346  252  94  72.8  27.2 
Later than  7th day  666  423  243  63.5  36.5 
totals ..........................  1,2~i  838  373  69.2  I  30.8 
The  pronounced influence of  the  serum  is  strikingly  shown by 
these tabulations  which serve to  confirm the earlier figures given.  3 
2 Flexner,  S.,  ]our.  Exper.  Med.,  19o8,  x,  699. 
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In  some  instances  the precise period  of  first injection of the serum 
was  not stated  in the histories,  which  explains  the  smaller  number 
of  cases  analyzed  in  table  II.  This  table  not  only  establishes  the 
fact  that  the earlier  the  serum  injections  are  begun  the better  the 
results,  but  it  emphasizes  the  too  common  delay  in  making  the 
diagnosis  of  epidemic  meningitis  or  of  bringing  the  majority  of 
cases under the specific treatment.  Less than one sixth of the cases 
had the benefit of early injection,  and one half received the first in- 
jection later than the first week of illness.  Doubtless  as the serum 
is  made  more  generally  available  and  as  confidence  in  its  value 
extends, these disadvantages will be more and more removed. 
That  the mortality  is  affected by  the  age  of  the  patient  is  com- 
monly  admitted.  The  influence  of  the  serum  on  patients  of  dif- 
ferent ages is shown in table III. 
TABLE  III. 
Mortality according  to Age. 
Per cent.  Per cent. 
Age.  No. of cases.  Recovered.  Died.  recovered,  died. 
Under I  yr... 
r  to 2  yrs  ....... 
2  to 5 yrs.. 
5  to  ro yrs  ...... 
IO to 20 yrs. 
Over 2o yrs  .... 
Age not given... 
I29 
87 
I94 
218 
360 
288 
I8 
65 
60 
I39 
I85 
254 
I8o 
II 
I  894 
64 
27 
55 
33 
Io6 
Io8 
7 
50.4 
69.0 
71.6 
84.9 
70.6 
62.5 
6i.i 
49.6 
3I.O 
28.4 
rs.I 
29.4 
37-5 
38.9 
Totals ...........  1,294  400  I  69.I  [  30.9 
TABLE  IV. 
Mortality  according  to  Age and  Period  of Injection. 
to 7th day.  Injected later than 7  t 
A~e.  p2-  ~ 
Under 2  yrs  ....... 
2  to 5 yrs  ......... 
5 to  Io yrs  ........ 
IO to 20 yrs  ....... 
Over 2o yrs  ....... 
Totals ........... 
Injected xst to 3  d day.  Injected 4th 
No.  Re-  Per  No.  Re- 
of  coy-  Died.[  cent.  of  coy- 
case.,  ered.  died.  =ases  ered 
13  I2  I  I  7.7  37  28 
30  24  6  120.0  66  49 
55  49  6  I IO.9  69  6I 
67  58  9  113.4  Io6  73 
34  2o  I4  141.2  65  39 
I 
I99  163  !  36  1x8.I  343  25o 
Say. [ 
Per  No. 
Died.  cent.  I  of 
[ died.  cases 
9  24.3  I59 
~7  125.8l  93 
8  1iI.6  77 
33  131.I ] I7I 
26  4o.o  I64 
93  127-I I 664 
7th day. 
Re-  Per 
coy-  Died,  cent. 
ered.  died. 
8I  78  49.I 
63  30  37-3 
6x  I6  2o.8 
II5  56  32.7 
Ioi  63  38.4 
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Table IV gives an analysis of the data of the preceding tabulation 
according to the period of the disease at which the serum injections 
were begun. 
The age  factor affects the outcome of the serum treatment jus,t 
as  it  affects spontaneous  recovery, only its  influence is  even more 
marked in the  former.  The most  favorable  cases  for the  specific 
treatment  fall  between the  five and  ten year period  and  the  least 
favorable ones fall in the period above twenty years.  The favorable 
period  doubtless  extends  to  and  even  beyond  the  twentieth  year 
although the analysis given fails to make an exact discrimination for 
these ages.  To  subdivide  farther the periods  risks  increasing the 
statistical error inherent in small numbers ; but the reports of certain 
hospitals covering cases arising during the th.ird decennium indicate 
no great decrease in  response to  the serum.  What  is  particularly 
impressive is the change wrought in the fatality among infants, and 
while the astonishing result for the first injection period can scarcely 
be  maintained through the v.icissitudes of large numbers of cases, 
yet the outlook is highly promising.  The exact coincidence of the 
favorable ages for spontaneous recovery and for recovery under the 
serum  treatment  indicates  that  the  serum  provides  artificially the 
means that  the body  itself employs when it  can  fabricate them to 
suppress  the  infection, and  that  two  factors,  one provided  by the 
body and the other by the serum, coSperate in the end result.  The 
change wrought in the manner of termination of the disease enforces 
the same conclusion. 
MANNER  OF  TERMINATION  AND  DURATION. 
The usual mode of spontaneous termination of epidemic menin- 
gitis  is  by gradual  subsidence  of  the symptoms,  or lysis,  and  the 
exceptional mode i.s  by  abrupt  cessation,  or  crisis.  While  precise 
figures showing the number of cases subsiding by crisis in ordinary 
epidemics are not available, yet it can be said that it has never been 
observed to be large and that sometimes this class of cases has been 
wholly absent.  The histories of 83o cases embraced in our tabula- 
tion permitted of a judgment as to the manner of termination, and it 
was ascertained that in 3o per cent. the cessation was abrupt,  or by Simon Flexner.  567 
crisis.  In our previous tabulation of 4o0 cases  4 the percentage was 
placed at 2 5  , which apparently was too low. 
A  consideration of the manner of recovery according to the age 
groups brings out some facts of suggestive interest.  The data are 
given in table V,  from which it will be seen that among cases of all 
ages  termination by  crisis  and by  lysis  occurs about  equally when 
the injeotion of the serum was begun in the first three days of illness, 
while when the injection was begun later the number of cases termi- 
nating by lysis  rose steadily.  One other point is  indicated by the 
tabulation;  namely,  thaZ  the  proportion  of  cases  that  resolve  by 
crisis  is  highest  in  the  age  periods  more  favorable,  and  lowest  in 
those less  favorable to  recovery, whether spontaneously or through 
specific treatment. 
TABLE  V. 
Recovery  by Lysis  or Crisis according  to  Age  Periods. 
Under  i  yr. 
By lysis ............ 
By crisis ........... 
I  to  2  yrs. 
By lysis ............ 
By crisis ............ 
2  to  5  yrs. 
By lysis ............. 
By crisis ............ 
i 
5  to  IO yrs. 
By lysis ............. 
By crisis ............ 
io to 20 yrs. 
By lysis ............. 
By crisis ............ 
Over 20 yrs. 
By lysis ............. 
By crisis ............ 
zst to 3 d day.  4th to  7th day.  i Later than  7th day.  Total. 
IO 
I4 
26 
23 
28 
30 
II 
9 
IO 
6 
31 
18 
43 
18 
46 
27 
22 
17 
36 
8 
26 
8 
53 
IO 
43 
19 
9 2 
23 
85 
14 
45 
i6 
4 ° 
17 
94 
42 
I12 
60 
I66 
80 
118 
40 
With the manner of termination is obviously bound up the period 
of  duration  of  the  active  symptoms  of  the  disease.  Epidemic 
meningitis  pursuing  its  usual  or  typical  course  passes  through  a 
series  of  reinfections  of  the  cerebrospinal  meninges,  whence  its 
intermittent or remittent character.  To  determine, therefore, just 
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what constitutes a  relapse of the infection is  sometimes difficult or 
even  impossible.  The  most  trustworthy  guide,  next  to.  long  and 
complete  irrtermission of  symptoms,  is  afforded by bacteriological 
examination of the cerebrospinal liquid, since the meningococci tend 
not to disappear wholly during the intermissions, while they do  so 
disappear between true relapses.  Having in mind these criteria we 
have separated from the  1,294 cases 56  that showed relapses after 
greater or less intervals of time.  Prompt resumption of the serum 
injections often but  not invariably sufficed to  control and  suppress 
the  reinfections.  Of  the  56  cases  4o  recovered  and  16  died. 
Among them the mortality was  28.6  per cent.,  indicating that  the 
relapses respond somewhat less well to the serum than the primary 
infections. 
RESPONSE  OF  RESISTANT  OR  FAST  STRAINS. 
In some instances the meningococci having been at  first  readily 
controlled by the injections appear to develop resistance or fastness 
to the serum.  This has been noted in certain cases o.f relapse going 
on to  a  fatal termination.  Hence under special circumstances the 
meningococci  seem  to  acquire  a  serum-fastness  that  thwarts  its 
specific action.  A  variety of serum-fast meningococci exists  in  a 
small  number,  at least,  of cases of epidemic meningitis before the 
serum has been applied.  This  original  fast strain seems not to be 
of common occurrence and  its biological  properties  have  not been 
minutely studied.  It is not known whether serum fastness and in- 
disposition to opsonization and leucocytic digestion go hand in hand 
or not.  Nor is it known whether merely one or many fast strains 
distinct  from one  another exist  in  nature.  Information  on  these 
points is highly desirable, as is the utilization of fast strains of the 
meningococcus  in  the  preparation  of  the  antimeningitis  serum. 
Should a true polyvalent serum of high titre carrying immune bodies 
for the  fast  strains  be  developed it  is  probable  that  the mortality 
percentages would come to be depressed still further. 
COMPLICATIONS  AND  SEQUELS. 
The number of cases here analyzed should serve to  indicate the 
frequency with which the usual  complications and sequels may be 
met with under the serum mode of treatment.  Our earlier tabula- Simon Flexner.  569 
tion suggested that the recoveries would, as a  rule, be complete and 
the one severe sequel that would still remain,  although in diminished 
degree, is deafness.  It is impossible to know whether the histories 
returned  noted  all  the  sequels,  but  it  is  probable  that  the  severer 
ones,  which we are considering,  were uniformly  recorded.  I  have 
tabulated the reported instances  of impaired hearing and vision and 
arthritis  in relation to the day of the  disease on which  the  first in- 
jection of serum was made.  The  circumstance  that  sometimes the 
defect  already  existed  when  the  injection  was  made  can  be  disre- 
garded,  since,  as  this  fact  cannot  always  be  established  and  as  a 
specific form of treatment may be presumed to be capable, at times, 
of suppressing  the  secondary localizations  of the  meningococci,  no 
exclusion should be practiced. 
TABLE  VI. 
Impaired  Hearing  and  Vision  and  Arthritis  in  Serum-Treated  Cases. 
Day of disease of first serum injection. 
No.  of cases in which  deafn  .ss occurred  ........ 
No.  of cases in which  impaired  v  sion occurred.. 
No.  of cases in which  arthritis  occurred  ........  I  /513i 1  /  /  !21 
The  instances  of  arthritis  all  recovered,  as  is  the  rule;  and  the 
recovery could be hastened  by injecting  the  serum  directly into the 
inflamed joint.  Deafness was complete in 39 .and partial in 6 of the 
45  instances.  Blindness  occurred  3  times,  some degree  of impair- 
ment  of  vision  6  times,  iridocyclitis,  choroiditis,  and  metastatic 
ophthalmia  (affecting one eye)  once each.  Impaired mentality oc- 
curred  3  times;  in  one  instance  the  state  is  described  as  imbecile. 
Muscular paralyses were recorded in I I histories as follows : strabis- 
mus in 5, paralysis of the lower extremity in 3, of the face in 2, and 
of the shoulder in  I.  Deafness and impaired vision were combined 
in 2  cases,  imbecility and  impaired  vision and  arthritis  and  choroi- 
ditis  occurred  in  I  case  each. 
The  severe  and  permanent  sequels  are  those  resulting  from 
affections of the  internal  ear and  the  essential  structures  of vision. 
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This  constitutes a  marked reduction of  the percentages that  have 
been  observed  among the  spontaneously recovered;  whether  they 
can be still further diminished by a  more prompt and vigorous em- 
ployment of the serum cannot be predicted. 
DISCUSSION. 
The  foregoing analyses  demand merely a  brief  discussion since 
they carry  their own  forceful argument.  They show  indubitably 
that the mortality of epidemic meningitis can be greatly reduced by 
the application of the specific serum treatment and the extent of the 
reduction  is  determined by  two  main  factors:  the  period  of  the 
disease at which the subdural injections of the serum are begun and 
the  ages  of  the  persons  affected.  In  view  of  the  fact  that  the 
average mortality during the pandemic was  approximately  7  °  per 
cent., the gross reduction was somewhat less than two thirds.  On 
the other hand,  the statistics  presented indicate that  general  early 
diagnosis and prompt institution of the serum treatment are capable 
of still further depressing the mortality. 
Although  at  first  regarded  as  doubtful  it  now  appears  that 
fulminant cases of epidemic meningitis are not wholly without the 
sphere of beneficial influence of the serum.  This conclusion rests, 
first, upon specific statements of recovery of such cases under the 
influence of the serum, and, next, upon the definite change wrought 
by it in the mortality of the disease during the first three days of 
prevalence which is  the period  during  which  the  fulminant  cases 
terminate  in  death.  Flatten's  figures  (page  559)  and  the  figures 
given in table II afford a basis  for comparison covering this point. 
Undoubtedly it is the ordinary type of epidemic meningitis that 
responds best to the specific treatment.  This fact is shown not only 
by  the  general  reduction  in  mortality,  but  also  by  the  common 
alteration of the manner of its termination from lysis to crisis.  It 
is just this transformation and the general shortening of the whole 
course of the disease and the consequent suppression of the chronic 
form  of  the  infection  that  bring  conviction of  the  value  of  the 
serum not only by reason of statistical presentations but even more 
cogently to the hospital physicians who have large experience with 
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Other objective criteria of the action of the serum exist.  One of 
the  most  conclusive  is  the  effect  exerted  upon  the  meningococci 
through which multiplication is arrested and phagocytosis and intra- 
leucocytie digestion  accelerated.  This  impressive  evidence of  the 
action  of  the  serum  has  been  recorded  many  times  by  different 
physicians in the histories upon which this paper is based 
The complications and  sequels  are reduced in  number.  Indeed, 
the  number  of  permanently injured among the  serum-treated has 
become  very  small.  Of  all  the  severe  sequels  deafness  has  re- 
mained  least  influenced.  Unhappily,  injury  to  the  internal  ear 
takes place very early and sometimes before the diagnosis of men- 
ingitis  has  been  made.  In  view  of  the  great  reduction  in  other 
severe effects we are permitted to hope that even this  one may be 
diminished  by  a  more  uniformly early  application  of  the  serum. 
The arthropathies have not only been reduced in frequency but they 
have been shown to be amenable to  direct injections of the serum. 
Undoubtedly the tendency to hydrocephalus in the young has been 
diminished,  and  the  intraventricular  injection  of  the  serum  has 
operated in several instances to  abolish  infection and inflammation 
of the cerebral ventricles and to refistablish communication between 
the ventricles and the subdural space of the spinal cord.  Recovery, 
therefore, has been rendered complete. 
III. 
ADDENDUM. 
In the preceding presentment the value of the serum treatment is 
based  wholly  upon  the  experience gained  by  the  Rockefeller  In- 
stitute  during  the  several  years  it  was  engaged  in  preparing  and 
distributing  the  antimeningitis  serum.  Three reports  on the  sub- 
ject have been issued at different times; this report is the final one, 
since the Institute no longer prepares the serum and is collecting no 
more  histories  of  cases  treated  with  it.  During  the  period  of 
several years in  which the serum was  on trial,  reports  from other 
countries have also  been published.  The most  important  possibly 
are those of Levy and Netter.  They support the value of the serum 
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two years  two widely remote  epidemics  of meningitis  came  under 
the  serum  treatment,  of  which  the  results  are  now  available  for 
study.  One occurred  in  Greece, the other  in  the  Southwest of the 
United  States.  Of  the  former  a  set  of  figures  from  Athens  has 
been  published.  The  serum  employed  was  chiefly  that  prepared 
at  the  Rockefeller Institute  and  the  cases  were  treated  at  the  An- 
nunciation  Hospital  by Dr.  Chrestoman6s.  The  tabulation  which 
follows gives the main important  facts which are in complete accord 
with the corresponding data of our previous tabulation  (table II). 
TABLE  VII. 
Serum-Treated  Cases  of the  Grecian  Epidemic,  ~9~I-I2. 
Per cent. 
Period of injection.  No. of cases.  Recovered.  Died.  died. 
Ist to 3d day .........  IOO  87  13  I3.o 
4th to 7th day ........  54  40  14  25.9 
Later than  7th day ....  32  17  15  47.0 
I 
Totals ................  i  I86  144  42  22.6 
During  the  past  two  winters  (1911-12,  1912-13)  Texas,  Loui- 
siana,  and  still  other  southern  and  western  states  have  suffered  in 
some degree from an extension or reappearance  of epidemic menin- 
gitis.  The  serum  was employed in many  of the  cases,  and  the  re- 
ports  from Texas 5 and Louisiana are available  for  1911-12.  They 
are  specially valuable since they indicate what  can be accomplished 
by the employment of the  serum not only inside  hospitals  but out- 
side  and,  as  often  happens,  under  the  disadvantages  of  poor  sur- 
roundings and,  doubtless, by physicians without previous experience 
in the performance of lumbar puncture. 
The total cases reported from the cities  (exclusive of Dallas)  and 
counties in Texas numbered 1,956.  Of them 562 received no serum 
and  the mortality was 77 per cent.  1,394 were given one or more 
injections  of the  serum  and  the mortality  was  37 per cent.  Since 
the conditions  for the care of patients  tend to be better in the cities 
than  in  country  districts,  any  treatment  is  likely to  be carried  out 
more effectively in them.  The  figures  for three cities that  suffered 
heavily in the epidemic follow. 
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Galveston : 
Houston : 
Dallas" : 
Dallas  * : 
83  cases  treated  with  the  serum;  mortality  24  per  cent. 
169  cases  treated  with  the  serum:  mortality  27  per  cent. 
444  cases  treated  with  the  serum;  mortality  27  per  cent. 
18o  cases  treated  with  the  serum;  mortality  25  per  cent. 
The  preceding  figures  are  uncorrected  and  include  all  cases  re- 
ceiving  the  serum  without  reference  to  the  quantity  given  or  the 
period  of  the  disease  when  first  treated.  Not  a  few  cases  came 
under  treatment  when  already  moribund.  Among  the  group  of 
cases  observed by  Dr.  Sophian  19  were  in  a  dying  condition  when 
first  given  the  serum  and  survived  the  injection  less  than  twenty- 
four hours.  Excluding  these almost hopeless  examples  lowers  the 
mortality among the  161  remaining cases to  15. 5 per cent. 
TABLE  VIII. 
Shreveport  Epidemic,  r9z2. 
Serum-treated.  ~'on-serum-treated. 
Total No.  Recovered 
of  cas__..,  es__ --i 
176  [  123 
Died 
53 
Mortality according to Race. 
Serum-treated.  Non-serum-treated. 
Per  Per 
cent.  Total No.  Recovered.  Died.  cent. 
died.  of cases,  died. 
II  ]  63  85.0  3o.I  74  i 
Per  I 
Total.  Recovered.  Died.  cent.  I 
died. I 
cW~o  liTe  ~t  67  47  [  20  29.8  [ 
".'.'. ~iii  109  76  [  33  I  30.3  I 
Recovered.  Total.  Died. 
27  7  20 
47  4  43 
Per 
cent. 
died. 
74.0 
91.5 
The data given in the official report of the Louisiana State Board 
of Health  relating to the  Shreveport epidemic may be  studied  from 
various  points  of  view.  The  total  cases  numbered  25o.  The 
results  of my analysis  of  the cases  are  presented  in  the  tabulation. 
The  chief  facts  may be stated  as  follows:  the mortality  among the 
non-serum-treated  cases  was  85  per  cent.,  and  among  the  serum- 
treated 3o per cent. ; white and colored patients responded equally to 
the  serum,  but  without  serum  the  colored  patients  succumbed  in 
s Reported  by  Dr.  Nash. 
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greater proportion than the white.  Doubtless this difference arose 
from  the  generally poorer  surroundings  and  care  of  the  colored 
race  rather  than  from  any  inherent  lack  of  resistance  to  the  in- 
fection.  As  a  rule,  the  number of  injections  and  the  amount  of 
serum administered have been given in the report.  Where the ad- 
ministration was obviously futile the case has been reclassified. 
CONCLUSION. 
The data brought together in this report have been gathered from 
a wide territory and for a period extending over several years.  The 
antimeningitis  serum  was  first  employed  in  19o6  and  the  latest 
figures relating to its use included in this  report were furnished in 
I912.  There is no longer doubt that the serum has come to be ap- 
plied under conditions fairly representing all known manifestations 
of epidemic meningitis.  Hence the test of the serum treatment may 
be regarded as having been a  rigorous one.  The initial  difficulties 
surrounding  the  administration  by  direct  subdural  injection  have 
been largely overcome and doubtless will be still  further mastered. 
Already the serum is being successfully applied in private as well as 
in hospital practice.  This gain will probably be reflected in a  still 
further diminution of the mortality since early injection plays such 
a  large part in determining the results achieved. 
The  1,3oo  cases  studied  in  this  report  are  a  part  only of  a  far 
greater number of cases actually treated with the serum supplied by 
the  Rockefeller  Institute.  It  was  not  found  possible  to  secure 
histories of all the cases treated; but  there is  no reason to suppose 
that the results of the analysis would have been essentially different 
if reports of a still larger number of cases had been returned.  The 
decision arrived at is not based upon statistical computations alone, 
but upon objective data as well that are not readily misinterpreted. 
The conclusion that follows was first stated in  I9o  9  as the result 
of an analysis of 400  serum-treated cases.  It  is  supported by the 
study of the larger series of cases just presented. 
"In view of the various considerations presented, the conclusion 
may be drawn that the antimeningitis serum, when used by the sub- 
dural method of injection, in suitable doses and at proper intervals, 
is  capable of reducing the period of illness; of preventing, in large Simon  Flexner.  575 
measure,  the chronic lesions  and  types of the  infection; of bringing 
about complete restoration  of health,  in all but  a  very small  number 
of  the  recovered,  thus  lessening  the  serious,  deforming,  and 
permanent  consequences  of meningitis;  and  of  greatly  diminishing 
the  fatalities  due  to the  disease." 
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